Aravive Biologics
Houston, US · Delaware corporation
Founders & leadership
XE
Xin Eric ZhangNamed on SEC filing
VS
Vinay ShahNamed on SEC filing
AG
Amato GiacciaNamed on SEC filing
KL
Karen LiuNamed on SEC filing
RT
Ray TabibiazarNamed on SEC filing
SE
Stephen EckNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$363.3K disclosed across 1 round · 2017
▶$363.3KraisedJul 2017 · 1 investors · BiotechnologyRule 506(b)
▶$363.3KraisedJul 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Xin Eric ZhangDirector
- Vinay ShahExecutive Officer
- Amato GiacciaExecutive Officer, Director
- Karen LiuDirector
- Ray TabibiazarExecutive Officer, Director
- Stephen EckExecutive Officer, Director
- Offering amount
- $363.3K
- Amount sold
- $363.3K
- Minimum investment
- $363.3K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aravive Biologics raised?
- Aravive Biologics has disclosed $363.3K raised across 1 round.
- Where is Aravive Biologics headquartered?
- Aravive Biologics is headquartered in Houston, US.